多发性骨髓瘤合并骨髓瘤性胸腔积液6例单中心临床分析
Single-Center Clinical Analysis of 6 Cases with Multiple Myeloma and Myelomatous Pleural Effusion
DOI: 10.12677/acm.2025.1561854, PDF,    国家自然科学基金支持
作者: 冯 艺, 王芝涛, 翟志敏*：安徽医科大学第二附属医院血液内科，安徽 合肥
关键词: 多发性骨髓瘤；骨髓瘤性胸腔积液；流式细胞术；Multiple Myeloma； Myelomatous Pleural Effusion； Flow Cytometry
摘要: 目的：探讨多发性骨髓瘤(MM)合并骨髓瘤性胸腔积液(MPE)患者的临床特点及预后。方法：选取2018年10月至2023年10月安医大第二附属医院收治的6例MM合并MPE患者，对其临床资料、实验室检查结果及预后进行回顾性分析。结果：所有病例均通过流式细胞术(FCM)或胸腔积液细胞学确诊，其中IgG型4例，IgD型及轻链型各1例。患者中位年龄64.5岁(52~71岁)，男女比为1:1。随访结果显示5例患者死亡，1例失访。结论：MM合并MPE临床罕见，患者预后较差。积液细胞形态学和流式细胞术(FCM)免疫表型检查是诊断MPE的主要依据。
Abstract: Objective: To investigate the clinical characteristics and prognosis of patients with multiple myeloma (MM) complicated by myelomatous pleural effusion (MPE). Methods: A retrospective analysis was conducted on 6 MM patients with MPE admitted to the Second Affiliated Hospital of Anhui Medical University between October 2018 and October 2023. Clinical data, laboratory findings, and outcomes were reviewed. Results: All cases were confirmed by flow cytometry (FCM) or cytological examination of pleural effusion, including 4 IgG-type, 1 IgD-type, and 1 light-chain-type cases. The median age was 64.5 years (range: 52~71), with a male-to-female ratio of 1:1. Follow-up revealed 5 deaths and 1 lost case. Conclusion: MM with MPE is clinically rare and associated with poor prognosis. Cytomorphology and FCM immunophenotyping are key diagnostic tools for MPE.
文章引用：冯艺, 王芝涛, 翟志敏. 多发性骨髓瘤合并骨髓瘤性胸腔积液6例单中心临床分析[J]. 临床医学进展, 2025, 15(6): 1310-1316. https://doi.org/10.12677/acm.2025.1561854

参考文献

[1] Usmani, S.Z., Heuck, C., Mitchell, A., Szymonifka, J., Nair, B., Hoering, A., et al. (2012) Extramedullary Disease Portends Poor Prognosis in Multiple Myeloma and Is Over-Represented in High-Risk Disease Even in the Era of Novel Agents. Haematologica, 97, 1761-1767. [Google Scholar] [CrossRef] [PubMed]
[2] Varettoni, M., Corso, A., Pica, G., Mangiacavalli, S., Pascutto, C. and Lazzarino, M. (2010) Incidence, Presenting Features and Outcome of Extramedullary Disease in Multiple Myeloma: A Longitudinal Study on 1003 Consecutive Patients. Annals of Oncology, 21, 325-330. [Google Scholar] [CrossRef] [PubMed]
[3] Kumar, S.K., Dispenzieri, A., Lacy, M.Q., Gertz, M.A., Buadi, F.K., Pandey, S., et al. (2013) Continued Improvement in Survival in Multiple Myeloma: Changes in Early Mortality and Outcomes in Older Patients. Leukemia, 28, 1122-1128. [Google Scholar] [CrossRef] [PubMed]
[4] Kamble, R., Wilson, C., Fassas, A., Desikan, R., Siegel, D., Tricot, G., et al. (2005) Malignant Pleural Effusion of Multiple Myeloma: Prognostic Factors and Outcome. Leukemia & Lymphoma, 46, 1137-1142. [Google Scholar] [CrossRef] [PubMed]
[5] Kanagarajah, P., Cao, K., Chen, L. and Rumbak, M. (2018) Malignant Multiple Myeloma of the Pleura. Journal of Bronchology & Interventional Pulmonology, 25, 332-334. [Google Scholar] [CrossRef] [PubMed]
[6] Kintzer, J.S. (1978) Thoracic and Pulmonary Abnormalities in Multiple Myeloma. A Review of 958 Cases. Archives of Internal Medicine, 138, 727-730. [Google Scholar] [CrossRef] [PubMed]
[7] Byun, J.M., Kim, K.H., Choi, I.S., Park, J.H., Kim, J., Shin, D., et al. (2017) Pleural Effusion in Multiple Myeloma: Characteristics and Practice Patterns. Acta Haematologica, 138, 69-76. [Google Scholar] [CrossRef] [PubMed]
[8] Cho, Y., Chi, H., Park, C., Jang, S., Seo, E. and Suh, C. (2011) Myelomatous Pleural Effusion: A Case Series in a Single Institution and Literature Review. Annals of Laboratory Medicine, 31, 225-230. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, Z., Xia, G., Lan, L., Liu, F., Wang, Y., Liu, B., et al. (2016) Pleural Effusion in Multiple Myeloma. Internal Medicine, 55, 339-345. [Google Scholar] [CrossRef] [PubMed]
[10] Marchesi, F., Masi, S., Summa, V., Gumenyuk, S., Merola, R., Orlandi, G., et al. (2015) Flow Cytometry Characterization in Central Nervous System and Pleural Effusion Multiple Myeloma Infiltration: An Italian National Cancer Institute Experience. British Journal of Haematology, 172, 980-982. [Google Scholar] [CrossRef] [PubMed]
[11] Kim, Y.J., Kim, S.J., Min, K., Kim, H.Y., Kim, H.J., Lee, Y.K., et al. (2008) Multiple Myeloma with Myelomatous Pleural Effusion: A Case Report and Review of the Literature. Acta Haematologica, 120, 108-111. [Google Scholar] [CrossRef] [PubMed]
[12] 黄蓓晖, 李娟, 刘俊茹, 等. 多发性骨髓瘤并发髓外浸润的临床分析[J]. 临床血液学杂志, 2011, 24(2): 151-154, 157.
[13] Jancelewicz, Z., et al. (1975) IgD Multiple Myeloma. Review of 133 Cases. Archives of Internal Medicine, 135, 87-93. [Google Scholar] [CrossRef] [PubMed]
[14] Zhong, Y., Zhang, J. and Wang, H. (2015) Myelomatous Pleural Effusion Involvement in 23 Patients with Multiple Myeloma: A Single‐Center Clinical Analysis. Thoracic Cancer, 6, 359-362. [Google Scholar] [CrossRef] [PubMed]
[15] Raci-Wetherbee, E. and Dincer, H.E. (2012) IgG Myeloma Presenting as a Large Mediastinal Mass and Pleural Effusion. Journal of Bronchology & Interventional Pulmonology, 19, 65-67. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, L.L., Li, Y.Y., Hu, C.P., et al. (2014) Myelomatous Pleural Effusion as an Initial Sign of Multiple Myeloma—A Case Report and Review of Literature. Journal of Thoracic Disease, 6, E152-E159.
[17] Agarwal, A., Klair, J., Patolia, S. and Meena, N.K. (2015) Intrapleural Cisplatin for Management of Malignant Pleural Effusion in a Patient with Plasma Cell Leucaemia. BMJ Case Reports, 2015, bcr2015210044. [Google Scholar] [CrossRef] [PubMed]
[18] 应双伟, 胡敏利, 邵燕萍, 等. 骨髓瘤性胸腔积液6例临床分析[J]. 浙江医学, 2019, 41(4): 365-367.
[19] Iqbal, N., Tariq, M.U., Shaikh, M.U. and Majid, H. (2016) Pleural Effusion as a Manifestation of Multiple Myeloma. BMJ Case Reports, 2016, bcr2016215433. [Google Scholar] [CrossRef] [PubMed]
[20] Ye, W., Wang, J., Li, W. and Shen, H. (2019) Comparative Analysis of Flow Cytometry and Cytomorphology for Neuroblastoma Cell Detection in Effusion and Bone Marrow Specimens. Fetal and Pediatric Pathology, 38, 1-7. [Google Scholar] [CrossRef] [PubMed]
[21] Iannitto, E., Minardi, V. and Tripodo, C. (2007) Use of Intrapleural Bortezomib in Myelomatous Pleural Effusion. British Journal of Haematology, 139, 621-622. [Google Scholar] [CrossRef] [PubMed]

为你推荐